Date Initiated by Firm | December 11, 2019 |
Create Date | February 05, 2020 |
Recall Status1 |
Terminated 3 on September 04, 2020 |
Recall Number | Z-1056-2020 |
Recall Event ID |
84530 |
Product Classification |
Breast biopsy / localization tray - Product Code PXP
|
Product | Centurion-
SPEC0002B ARTHROGRAM TRAY
SPEC0002B ARTHROGRAM TRAY
SPEC0004C ARTHROGRAM TRAY
SPEC0071B CUSTOM BX TRAY
SPEC0076G STEREO BIOPSY PACK-LF
SPEC0122 BASIC BIOPSY TRAY
SPEC0130B BREAST BIOPSY TRAY
SPEC0158A CT BIOPSY TRAY
SPEC0248B GENERAL BIOPSY TRAY- LF
SPEC0265A 22G FACET TRAY
SPEC0313 CYST ASPIRATION TRAY-LF
SPEC0313 CYST ASPIRATION TRAY-LF |
Code Information |
Lot Numbers: SPEC0002B ARTHROGRAM TRAY 2019032090 SPEC0002B ARTHROGRAM TRAY 2019021890 SPEC0004C ARTHROGRAM TRAY 2019031290 SPEC0071B CUSTOM BX TRAY 2019022590 SPEC0076G STEREO BIOPSY PACK-LF 2019040590 SPEC0122 BASIC BIOPSY TRAY 2019011790 SPEC0130B BREAST BIOPSY TRAY 2019020590 SPEC0158A CT BIOPSY TRAY 2018122090 SPEC0248B GENERAL BIOPSY TRAY- LF 2019012990 SPEC0265A 22G FACET TRAY 2019010290 SPEC0313 CYST ASPIRATION TRAY-LF 2019061290 SPEC0313 CYST ASPIRATION TRAY-LF 2019021290 |
Recalling Firm/ Manufacturer |
Centurion Medical Products Corporation 100 Centurion Way Williamston MI 48895-9086
|
For Additional Information Contact | SAME 517-546-5400 |
Manufacturer Reason for Recall | Incomplete seals on the sterile package may compromise the sterility |
FDA Determined Cause 2 | Packaging process control |
Action | Centurion issued a notification emailed to Medline Industries,
Centurion's parent company. Centurion issued mailing letters via First Class Mail beginning on 12/12/2019, letter states reason for recall, health risk and action to take: Please identify all inventory that you have within your possession and segregate it in a location where it cannot be accessed for use. 2) If you have transferred possession of this product to another individual, to another department or to another location in your organization, you are required by FDA regulations to notify them of this recall
communication. Please ask that any affected product be returned to you for collection. 3) Affected product is not to be returned to Centurion, and should be destroyed/discarded. Document the destruction of all product on the enclosed accountability record. 4) Please complete the enclosed accountability record, whether or not you have product, and fax or email at
your earliest convenience to the attention of Lisa Carpenter, Director of Quality Assurance Centurion Medical Products Corporation, (517) 546-5400 Ext.1122. |
Distribution | Nationwide
Foreign: GHANA |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|